Your browser doesn't support javascript.
loading
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.
Garbe, Claus; Forsea, Ana-Maria; Amaral, Teresa; Arenberger, Petr; Autier, Philippe; Berwick, Marianne; Boonen, Brigitta; Bylaite, Matilda; Del Marmol, Veronique; Dreno, Brigitte; Fargnoli, Maria Concetta; Geller, Alan C; Green, Adele C; Greinert, Rüdiger; Hauschild, Axel; Harwood, Catherine A; Hoorens, Isabelle; Kandolf, Lidija; Kaufmann, Roland; Kelleners-Smeets, Nicole; Lallas, Aimilios; Lebbé, Celeste; Leiter, Ulrike; Lim, Henry W; Longo, Caterina; Malvehy, Joseph; Moreno, David; Pellacani, Giovanni; Peris, Ketty; Robert, Caroline; Saiag, Philippe; Schadendorf, Dirk; Peter Soyer, H; Stockfleth, Eggert; Stratigos, Alex; Uhara, Hisashi; Vieira, Ricardo; Volkmer, Beate; Weinstock, Martin A; Whitaker, Dagmar; Zalaudek, Iris; Whiteman, David C; Brochez, Lieve.
Affiliation
  • Garbe C; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: claus.garbe@med.uni-tuebingen.de.
  • Forsea AM; Dermatology Department, Elias University Hospital, Carol Davila University of Medicine and Pharmacy Bucharest, Romania.
  • Amaral T; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Arenberger P; Department of Dermatovenereology, Charles University Third Medical Faculty and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Autier P; International Prevention Research Institute (i-PRI), Dardilly, France.
  • Berwick M; University of New Mexico Comprehensive Cancer Centre, Albuquerque, USA.
  • Boonen B; Belgian Cancer foundation, Brussels, Belgium.
  • Bylaite M; Faculty of Medicine, Centre of Dermatovenereology, Clinic of Infectious Diseases and Dermatovenereology, Vilnius University, Vilnius, Lithuania.
  • Del Marmol V; Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Dreno B; France Nantes University, Inserm 1302, INCIT, F-44000 Nantes, France.
  • Fargnoli MC; Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Geller AC; Department of Social and Behavioural Sciences, Public Health Campus, Boston, MA, USA.
  • Green AC; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Greinert R; Skin Cancer Centre, Laboratory for Molecular Cell Biology, Elbe Hospital Buxtehude, Buxtehude, Germany.
  • Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • Harwood CA; Department of Dermatology, Barts Health NHS Trust and Centre for Cell Biology and Cutaneous Research Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK.
  • Hoorens I; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Kandolf L; Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.
  • Kaufmann R; Department of Dermatology, Venerology and Allergology, Frankfurt University Hospital, Frankfurt, Germany.
  • Kelleners-Smeets N; GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Dermatology, Maastricht UMC+ Comprehensive Cancer Centre, Maastricht, the Netherlands.
  • Lallas A; First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.
  • Lebbé C; Université Paris Cite, AP-HP Dermato-oncology and CIC, Cancer institute APHP. Nord Paris Cité, France; INSERM U976, Saint Louis Hospital, Paris, France.
  • Leiter U; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Lim HW; Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
  • Longo C; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Skin Cancer Centre, Reggio Emilia, Italy.
  • Malvehy J; Department of Dermatology, Hospital Clínic de Barcelona (Melanoma Unit), University of Barcelona, IDIBAPS, Barcelona & CIBERER, Barcelona, Spain.
  • Moreno D; Medical-&-Surgical Dermatology Service. Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Pellacani G; Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy.
  • Peris K; Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy; UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
  • Robert C; Department of Medical Oncology, Gustave Roussy and Paris Saclay University, Villejuif, France.
  • Saiag P; Department of General and Oncologic Dermatology, Ambroise Paré hospital, APHP, & EA 4340 "Biomarkers in cancerology and haematooncology", UVSQ, Université Paris-Saclay, 92104 Boulogne-Billancourt, France.
  • Schadendorf D; Department of Dermatology & West German Cancer Centre, University Hospital Essen & German Cancer Consortium, Campus Essen & National Centre for tumour Diseases (NCT)-West, Campus Essen, Germany.
  • Peter Soyer H; Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
  • Stockfleth E; Department of Dermatology, Ruhr-University, Bochum, Bochum, Germany.
  • Stratigos A; First Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece.
  • Uhara H; Department of Dermatology, Sapporo Medical University, Sapporo, Japan.
  • Vieira R; Department of Dermatology and Venereology, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
  • Volkmer B; Skin Cancer Centre, Laboratory for Molecular Cell Biology, Elbe Hospital Buxtehude, Buxtehude, Germany.
  • Weinstock MA; Brown University and V A Medical Centre, Providence, RI, USA.
  • Whitaker D; Private Practice, Cape Town, South Africa.
  • Zalaudek I; Department of Dermatology and Venereology of the Hospital Clinics Giuliano Isontino (ASUGI), Maggiore Hospital, Trieste, Italy.
  • Whiteman DC; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Brochez L; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
Eur J Cancer ; 204: 114074, 2024 Jun.
Article de En | MEDLINE | ID: mdl-38691877
ABSTRACT
Cancers of the skin are the most commonly occurring cancers in humans. In fair-skinned populations, up to 95% of keratinocyte skin cancers and 70-95% of cutaneous melanomas are caused by ultraviolet radiation and are thus theoretically preventable. Currently, however, there is no comprehensive global advice on practical steps to be taken to reduce the toll of skin cancer. To address this gap, an expert working group comprising clinicians and researchers from Africa, America, Asia, Australia, and Europe, together with learned societies (European Association of Dermato-Oncology, Euromelanoma, Euroskin, European Union of Medical Specialists, and the Melanoma World Society) reviewed the extant evidence and issued the following evidence-based recommendations for photoprotection as a strategy to prevent skin cancer. Fair skinned people, especially children, should minimise their exposure to ultraviolet radiation, and are advised to use protective measures when the UV index is forecast to reach 3 or higher. Protective measures include a combination of seeking shade, physical protection (e.g. clothing, hat, sunglasses), and applying broad-spectrum, SPF 30 + sunscreens to uncovered skin. Intentional exposure to solar ultraviolet radiation for the purpose of sunbathing and tanning is considered an unhealthy behaviour and should be avoided. Similarly, use of solaria and other artificial sources of ultraviolet radiation to encourage tanning should be strongly discouraged, through regulation if necessary. Primary prevention of skin cancer has a positive return on investment. We encourage policymakers to communicate these messages to the general public and promote their wider implementation.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Rayons ultraviolets Limites: Humans Langue: En Journal: Eur J Cancer Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Rayons ultraviolets Limites: Humans Langue: En Journal: Eur J Cancer Année: 2024 Type de document: Article